{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:12:35Z","timestamp":1792707155289,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T00:00:00Z","timestamp":1640822400000},"content-version":"am","delay-in-days":273,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jiac.2020.11.012","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T22:18:17Z","timestamp":1609280297000},"page":"592-597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of positive IGRAs and innate immune system in HIV-infected individuals in Japan"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7754-3458","authenticated-orcid":false,"given":"Hidetoshi","family":"Igari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misuzu","family":"Yahaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizue","family":"Tsuyuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshibumi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiminori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2020.11.012_bib1","author":"World Health Organization"},{"key":"10.1016\/j.jiac.2020.11.012_bib2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1164\/ajrccm.162.2.9910055","article-title":"Tuberculosis in the homeless","volume":"162","author":"Moss","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2020.11.012_bib3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A\u00a0prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection","volume":"320","author":"Selwyn","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2020.11.012_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1473-3099(10)70078-5","article-title":"Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources","volume":"10","author":"Lawn","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2020.11.012_bib5","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1097\/QAD.0b013e3283320dfd","article-title":"Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?","volume":"23","author":"Grant","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2020.11.012_bib6","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1097\/00002030-200009080-00015","article-title":"Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection","volume":"14","author":"Girardi","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2020.11.012_bib7","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2020.11.012_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":"Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy","volume":"34","author":"Santoro-Lopes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.11.012_bib9","first-page":"1026","article-title":"The Adult\/Adolescent Spectrum of HIV Disease Group. HIV-associated tuberculosis in the era of highly active antiretroviral therapy","volume":"4","author":"Jones","year":"2000","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2020.11.012_bib10","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2020.11.012_bib11","article-title":"Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community","volume":"7","author":"Gupta","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2020.11.012_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.200410-1342OC","article-title":"Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan","volume":"172","author":"Seyler","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2020.11.012_bib13","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"1","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 3","key":"10.1016\/j.jiac.2020.11.012_bib14","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.1097\/QAI.0000000000000497","article-title":"Use of isoniazid preventive therapy for tuberculosis prophylaxis Among people living with HIV\/AIDS: a review of the literature","volume":"68","author":"Briggs","year":"2015","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiac.2020.11.012_bib15","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A\u00a0trial of early antiretrovirals and isoniazid preventive therapy in Africa","volume":"373","author":"Danel","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2020.11.012_bib16","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1016\/S2214-109X(17)30372-8","article-title":"Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial","volume":"5","author":"Badje","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jiac.2020.11.012_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","article-title":"Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort","volume":"23","author":"Golub","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2020.11.012_bib18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3201\/eid1502.080942","article-title":"Causes of death in HIV-infected persons who have tuberculosis, Thailand","volume":"15","author":"Cain","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2020.11.012_bib19","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil","volume":"21","author":"Golub","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2020.11.012_bib20","author":"World Health Organization"},{"key":"10.1016\/j.jiac.2020.11.012_bib21","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"L\u00f6nnroth","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2020.11.012_bib22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1183\/09031936.00205512","article-title":"Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination","volume":"42","author":"Diel","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2020.11.012_bib23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0140-6736(14)60162-8","article-title":"Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial","volume":"384","author":"Rangaka","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2020.11.012_bib24","first-page":"1190","article-title":"Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals","volume":"11","author":"Jones","year":"2007","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2020.11.012_bib25","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1128\/JCM.01054-12","article-title":"Prognostic value of indeterminate IFN-\u03b3 release assay results in HIV-1 infection","volume":"50","author":"Aichelburg","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2020.11.012_bib26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1164\/rccm.200608-1088OC","article-title":"Comparison of an interferon-\u03b3 release assay with tuberculin skin testing in HIV-infected individuals","volume":"175","author":"Luetkemeyer","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"15","key":"10.1016\/j.jiac.2020.11.012_bib27","article-title":"Poor concordance between interferon-\u03b3 release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals","volume":"9","author":"Talati","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2020.11.012_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004220","article-title":"The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis","volume":"4","author":"Aabye","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2020.11.012_bib29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals \u2013 a systematic review and meta-analysis","volume":"56","author":"Cattamanchi","year":"2011","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiac.2020.11.012_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107245","article-title":"Quantiferon-TB gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in C\u00f4te d'Ivoire, west Africa","volume":"9","author":"Danel","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2020.11.012_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.imlet.2018.04.001","article-title":"Impact of antiretroviral and tuberculosis therapies on CD4+ and CD8+ HIV\/M.tuberculosis-specific T-cell in co-infected subjects","volume":"198","author":"Chiacchio","year":"2018","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jiac.2020.11.012_bib32","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1182\/blood-2011-09-377523","article-title":"Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis","volume":"119","author":"Pean","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2020.11.012_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/QAI.0b013e31822e0d15","article-title":"Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV\/MTB coinfection","volume":"58","author":"Conradie","year":"2011","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiac.2020.11.012_bib34","first-page":"365","article-title":"Estimation of positive rates of interferon gamma release assay by age group","volume":"92","author":"Kato","year":"2017","journal-title":"Kekkaku"},{"key":"10.1016\/j.jiac.2020.11.012_bib35","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/QAD.0b013e3283188415","article-title":"Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country","volume":"22","author":"Stephan","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2020.11.012_bib36","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1164\/rccm.200610-1439OC","article-title":"Effect of HIV-1 infection on T-cell\u2013based and skin test detection of tuberculosis infection","volume":"175","author":"Rangaka","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2020.11.012_bib37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature10237","article-title":"HIV-1 adaptation to NK-cell-mediated immune pressure","volume":"476","author":"Alter","year":"2011","journal-title":"Nature"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20304190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20304190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:02:13Z","timestamp":1761159733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X20304190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1341321X20304190"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.11.012","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of positive IGRAs and innate immune system in HIV-infected individuals in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}